1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Grants and Giving Program is sponsored by Sarepta Therapeutics. Sarepta provides grant funding for programs that enable education, address unmet needs of rare disease patients, promote high standards of care, and raise awareness of ongoing research. While prioritizing Duchenne muscular dystrophy and limb-girdle muscular dystrophy, requests across the spectrum of neuromuscular and rare diseases are considered.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Advocacy groups, nonprofit organizations, academic institutions, scientific and medical associations, continuing medical education providers, and other organizations across the spectrum of neuromuscular and rare diseases. Confirm the full requirements in the official notice before applying.
Grants and Giving Program is funded by Sarepta Therapeutics. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Grants & Donations (Rare Diseases) is sponsored by Sarepta Therapeutics. Sarepta Therapeutics provides grant funding for programs that enable education, address unmet needs of rare disease patients, promote the highest standards of care, raise awareness of ongoing research, or focus on other critical community initiatives across the spectrum of neuromuscular and rare diseases.
Grants for Rare Disease Programs is sponsored by Sarepta Therapeutics. Sarepta provides grant funding for programs that enable education, address unmet needs of rare disease patients, promote the highest standards of care, raise awareness of ongoing research, or focus on other critical community initiatives. Requests are considered across the spectrum of neuromuscular and rare diseases, with priority given to Duchenne muscular dystrophy, limb-girdle muscular dystrophy, and other conditions. [16]